openPR Logo
Press release

Prostate Health Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

03-25-2025 08:05 AM CET | Health & Medicine

Press release from: The Business Research Company

Prostate Health

Prostate Health

What industry-specific factors are fueling the growth of the prostate health market?
The rising prevalence of prostate cancer is expected to drive the growth of the prostate health market. Prostate cancer, one of the most common cancers among men, is increasing due to factors such as an aging population, increased screening practices, and lifestyle factors like obesity and physical inactivity. Prostate health is crucial for the prevention, early detection, and treatment of prostate cancer. In 2023, it was estimated that there would be 288,300 new prostate cancer cases in the U.S. alone, with 34,700 fatalities. This growing prevalence of prostate cancer is expected to drive the market for prostate health treatments, supporting early detection, prevention, and effective management of the disease.

Get Your Prostate Health Market Report Here:
https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report

What Is the projected market size and growth rate for the prostate health market?
The prostate health market has grown strongly, increasing from $34.07 billion in 2024 to $37.34 billion in 2025 at a CAGR of 9.6%. Growth has been fueled by an aging male population, increased PSA screening, rising awareness campaigns, advancements in hormone therapy, and growing prostate cancer incidence rates.

The prostate health market is projected to witness significant growth in the coming years, reaching $53.25 billion by 2029 at a CAGR of 9.3%. This growth will be driven by the increasing adoption of precision medicine, expanding use of AI-driven diagnostics, advancements in targeted radiotherapies, rising demand for minimally invasive treatments, and improved genetic profiling for risk assessment. Key trends include AI-powered risk analysis, progress in liquid biopsy technology, next-generation radiotheranostics, advancements in immunotherapy, and real-time biomarker monitoring.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp

What new trends are reshaping the prostate health market and its opportunities?
Leading companies in the prostate health market are emphasizing technological advancements such as AI-based risk assessments to gain a competitive advantage. AI-powered risk assessments use algorithms to analyze data and predict potential risks, assisting in making informed decisions and improving outcomes. For example, in September 2024, Nanostics Inc., a clinical-stage biotechnology company from Canada, partnered with Protean BioDiagnostics, a US-based biotechnology company, to introduce CDX Prostate, a diagnostic tool aimed at men at risk of aggressive prostate cancer. This tool integrates biological data, clinical information, and AI-based learning models to generate a risk score for aggressive prostate cancer. CDX Prostate uses advanced machine learning algorithms to assess various biological and clinical data, offering a more accurate risk score for aggressive prostate cancer compared to traditional methods. The test helps healthcare providers and patients decide whether to proceed with a biopsy following a high prostate-specific antigen (PSA) test result or an abnormal digital rectal exam (DRE).

What major market segments define the scope and growth of the prostate health market?
The prostate health market covered in this report is segmented -

1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels

Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21265

Which region dominates the prostate health market?
North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the prostate health industry growth?
Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp

What Is Covered In The Prostate Health Global Market Report?

•Market Size Forecast: Examine the prostate health market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the prostate health market for a structured understanding.
•Key Players Overview: Analyze major players in the prostate health market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the prostate health market.
•Segment Contributions: Evaluate how different segments drive overall growth in the prostate health market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the prostate health market.
•Industry Challenges: Identify potential risks and obstacles affecting the prostate health market.
•Competitive Landscape: Review strategic developments in the prostate health market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostate Health Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here

News-ID: 3935211 • Views:

More Releases from The Business Research Company

Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR, Reaching $23.23 Billion by 2029
Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025? The market for subcutaneous immunoglobulin (SCIG) has seen a swift expansion in the recent past. The market size is projected to escalate from $12.72 billion in 2024 to $14.39 billion in 2025, reflecting a compound annual growth
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ranibizumab Market Size By 2025? The market for ranibizumab has experienced steady expansion in the past few years, with projections stating it will increase from $2.66 billion in 2024 to $2.76 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.6%. The growth
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships In Peptide And Oligonucleotide CDMO Market Boost Technological Capabilities And Market Reach Shaping the Future of the Industry
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Peptide And Oligonucleotide CDMO Market Size Growth Forecast: What to Expect by 2025? In recent years, the peptide and oligonucleotide cdmo market has witnessed a swift escalation in its size. From $2.16 billion in 2024, it is projected to surge up to $2.42 billion in 2025 with a compound
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chronic Disease Prevalence Drive Growth In The Oral Solid Dosage Pharmaceutical Formulation Market Market in 2025
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chroni …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oral Solid Dosage Pharmaceutical Formulation Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for oral solid dosage pharmaceutical formulations has seen robust growth in the last few years. Its size is expected to increase from $618.34 billion in 2024 to $653.26 billion in

All 5 Releases


More Releases for Prostate

04-14-2025 | Health & Medicine
Getnews
The 3D Urology and Prostate Clinics Introduces Innovative Natural and Targeted P …
The 3D Urology and Prostate Clinics introduces its innovative 3D targeted injection therapies, offering effective, natural solutions for various prostate conditions including prostatitis, enlarged prostate, and prostate cancer. Renowned for its pioneering approach to prostate health, The 3D Urology and Prostate Clinics is bringing renewed hope to patients worldwide suffering from various prostate diseases. Utilizing advanced diagnostic techniques and a unique targeted injection method, the clinics offer specialized treatments that focus
12-10-2024 | Health & Medicine
Getnews
The 3D Urology and Prostate Clinics Introduces Advanced 3D Prostate Targeted Tre …
The 3D Urology and Prostate Clinics announces its latest breakthrough in targeted prostate treatment, offering a revolutionary approach to prostate cancer and other prostate-related conditions. The 3D Urology and Prostate Clinics, renowned for its advanced techniques in prostate health, is proud to present its groundbreaking 3D prostate Targeted Treatment, a comprehensive and non-invasive solution for men suffering from prostate conditions. The clinic's innovative treatment is designed to target the root causes
11-29-2024 | Health & Medicine
Getnews
The 3D Urology and Prostate Clinics Unveil Innovative 3D Prostate Targeted Treat …
The 3D Urology and Prostate Clinics introduce their groundbreaking 3D prostate targeted treatment, offering a non-invasive solution for prostate health issues. The 3D Urology and Prostate Clinics, renowned for their specialized treatments in prostate health, are proud to unveil their innovative 3D prostate targeted treatment. This cutting-edge therapy provides a non-invasive, highly effective solution for prostate-related conditions, offering patients a new path to recovery and well-being.Image: https://i.imgur.com/NCfbb6S.jpg At the heart of this
07-29-2024 | Health & Medicine
Getnews
The 3D Urology and Prostate Clinics Unveils Advanced 3D prostate Targeted Treatm …
The 3D Urology and Prostate Clinics is at the forefront of prostate care, offering the advanced 3D Targeted Therapy as a precise and effective treatment solution. The 3D Urology and Prostate Clinics is proud to announce its revolutionary 3D prostate Targeted Treatment [http://www.3dprostatecure.com/page.php?cata_id=19], setting a new standard in prostate care. This highly advanced treatment option utilizes cutting-edge technology to deliver focused treatment, minimizing side effects and enhancing recovery for patients. Men
3D Prostate Cure: Revolutionizing Prostate Treatment with Targeted Therapy
This news release highlights the 3D Urology and Prostate Clinics' innovative approach to prostate treatment using 3D Targeted Therapy, offering a safe and effective alternative to traditional methods. As a global leader in men's health, The 3D Urology and Prostate Clinics is committed to providing cutting-edge treatments for various prostate conditions. The clinic is proud to announce its revolutionary 3D Targeted Therapy, offering a new standard in prostate care. This innovative therapy
06-22-2024 | Health & Medicine
Getnews
The 3D Urology and Prostate Clinics Enhance Prostate Health with Advanced 3D Pro …
The 3D Urology and Prostate Clinics are revolutionizing prostate care with their comprehensive treatments, including the 3D prostate Targeted Treatment and 3D Targeted Therapy, developed to ensure effective, non-surgical solutions for prostate health issues. At the forefront of prostate health, The 3D Urology and Prostate Clinics are excited to offer innovative treatments such as the 3D prostate Targeted Treatment and 3D Targeted Therapy. These treatments are part of the clinic's commitment